PLSE insider trading
NasdaqCM HealthcarePULSE BIOSCIENCES, INC.: insider trade history from SEC Form 4 filings.
About PULSE BIOSCIENCES, INC.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Company website: www.pulsebiosciences.com
PLSE insider activity at a glance
FilingIQ tracks 264 insider transactions for PLSE in filings since Feb 22, 2017. The most recent transaction is dated Sep 1, 2026.
Across the full history, 133 open-market purchases
and 23 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on PLSE insider trades is 52.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest PLSE Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading PLSE
Frequently asked
- How many insider trades does FilingIQ track for PLSE?
- FilingIQ tracks 264 Form 4 insider transactions for PLSE (PULSE BIOSCIENCES, INC.), covering filings from Feb 22, 2017 onwards. 4 of those are dated within the last 90 days.
- Are PLSE insiders net buyers or net sellers?
- Across the full Form 4 history for PLSE, 133 transactions (50%) were open-market purchases and 23 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does PLSE insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is PLSE in?
- PULSE BIOSCIENCES, INC. (PLSE) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $1.32B.
Methodology & sources
Every PLSE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.